A Study of ONO-1110 in Patients With Social Anxiety Disorder

Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)

NCT02622958 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder

NCT06809179 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder

NCT00294346 ·Status: COMPLETED ·Phase: PHASE2

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

NCT00191022 ·Status: COMPLETED ·Phase: PHASE2

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

NCT06615557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of NTX-1472 in Social Anxiety Disorder

NCT07323784 ·Status: RECRUITING ·Phase: PHASE2

Study of Escitalopram in the Treatment of Specific Phobia

NCT00121069 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of Vilazodone to Treat Social Anxiety Disorder

NCT01712321 ·Status: UNKNOWN ·Phase: NA

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

NCT06358651 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

NCT05729373 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Acceptability/Feasibility Testing of SCAR

NCT04859790 ·Status: UNKNOWN ·Phase: NA

Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia

NCT01217788 ·Status: COMPLETED ·Phase: PHASE2

Nefazodone in the Treatment of Social Phobia

NCT00231348 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder

NCT07193563 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

NCT07221578 ·Status: RECRUITING ·Phase: PHASE3

Xenon Inhalation for Treatment of Panic Disorder

NCT04432155 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia

NCT00515879 ·Status: COMPLETED ·Phase: PHASE3

Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety

NCT06564402 ·Status: RECRUITING ·Phase: NA

Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects

NCT00616655 ·Status: COMPLETED ·Phase: PHASE2

Long-term Study Of Paroxetine in Women and Men

NCT00264654 ·Status: COMPLETED ·Phase: PHASE3

Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders

NCT01288716 ·Status: COMPLETED ·Phase: PHASE2

A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder

NCT00555139 ·Status: COMPLETED ·Phase: PHASE1

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

NCT01470469 ·Status: COMPLETED ·Phase: PHASE2

Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)

NCT05030350 ·Status: TERMINATED ·Phase: PHASE3

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

NCT00114127 ·Status: COMPLETED ·Phase: PHASE3